Purchases and Sales Made in Q1 2025 in Atossa Therapeutics, Inc. (ATOS)
This table provides information about the institutional ownership of Atossa Therapeutics, Inc. (ATOS) during Q1 2025. The information is specifically focused on institutions that hold shares of ATOSSA THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-98.5K- 51.98% |
$66K - $99.5K
|
91K
$79.2K
|
|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-157K- 45.51% |
$105K - $159K
|
188K
$163K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-168K- 37.15% |
$113K - $170K
|
284K
$247K
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-242K- 67.08% |
$162K - $245K
|
119K
$103K
|
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
SELL
|
- |
-669K- 59.51% |
$448K - $676K
|
455K
$396K
|